Levothyroxine Sodium Injection
NDC 66794-201
Product Information
Levothyroxine Sodium is a ANDA-approved product labeled by Piramal Critical Care, Inc.. Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It is supplied as a injection for intravenous administration. This product entry covers the primary NDC 66794-201 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 66794-201?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVOTHYROXINE SODIUM ANHYDROUS (UNII: 054I36CPMN)
- LEVOTHYROXINE (UNII: Q51BO43MG4) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- MANNITOL (UNII: 3OWL53L36A)
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1115267 - levothyroxine sodium 100 MCG Injection
- RxCUI: 1115267 - levothyroxine sodium 0.1 MG Injection
- RxCUI: 966219 - levothyroxine sodium 500 MCG Injection
- RxCUI: 966219 - levothyroxine sodium 0.5 MG Injection
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.